Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on: April 10,2024

Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on:April 10,2024

Discovery of how to limit asthma attack damage could stop disease

byKing's College LondonCredit: CC0 Public DomainScientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-thre

Updated on: April 30,2024

Discovery of how to limit asthma attack damage could stop disease

byKing's College LondonCredit: CC0 Public DomainScientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-thre

Updated on:April 30,2024

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on: May 07,2024

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study

by Yolanda Poffenroth, Michael Brown,University of AlbertaCredit: Pixabay/CC0 Public DomainPermanent hearing loss triggered by a common chemotherapy drug in half of children being treated for ca

Updated on:May 07,2024

New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE

by American College of RheumatologyForest plot of clinical response in CLE with or without SLE in belimumab users vs. non-users at week 52. Credit: Significant Improvement in Cutaneous Lupus Eryt

Updated on: May 29,2024

New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE

by American College of RheumatologyForest plot of clinical response in CLE with or without SLE in belimumab users vs. non-users at week 52. Credit: Significant Improvement in Cutaneous Lupus Eryt

Updated on:May 29,2024

COVID vaccines also help protect HIV patients

by Ruhr-Universitaet-BochumAnti-RBD titers in vaccinated PLWH and HIV-negative controls. (A) Scheme showing the two groups of the study - control (n = 20) and people living with HIV (PLWH; n = 71

Updated on: April 09,2024

COVID vaccines also help protect HIV patients

by Ruhr-Universitaet-BochumAnti-RBD titers in vaccinated PLWH and HIV-negative controls. (A) Scheme showing the two groups of the study - control (n = 20) and people living with HIV (PLWH; n = 71

Updated on:April 09,2024

Filling data gaps: Gender equity in academic rheumatology

by European Alliance of Associations for Rheumatology, EULARTypical self-reported working hours in a week by role and gender, EULAR and EMEUNET members, 323 responses. The box and whisker chart shows

Updated on: June 01,2024

Filling data gaps: Gender equity in academic rheumatology

by European Alliance of Associations for Rheumatology, EULARTypical self-reported working hours in a week by role and gender, EULAR and EMEUNET members, 323 responses. The box and whisker chart shows

Updated on:June 01,2024

New strategy for COVID-19 prophylaxis

by University of BonnPhD student Samira Marx and Prof. Dr. Gunther Hartmann - of the Cluster of Excellence ImmunoSensation2 at the University of Bonn in the lab. Credit: David FußhöllerSARS-CoV-2

Updated on: April 13,2024

New strategy for COVID-19 prophylaxis

by University of BonnPhD student Samira Marx and Prof. Dr. Gunther Hartmann - of the Cluster of Excellence ImmunoSensation2 at the University of Bonn in the lab. Credit: David FußhöllerSARS-CoV-2

Updated on:April 13,2024

Preventing cell death as novel therapeutic strategy for rheumatoid arthritis

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainA collaborative study has identified a new molecular mechanism causing rheumatoid arthritis. The researchers found that d

Updated on: March 30,2024

Preventing cell death as novel therapeutic strategy for rheumatoid arthritis

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainA collaborative study has identified a new molecular mechanism causing rheumatoid arthritis. The researchers found that d

Updated on:March 30,2024

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli

Updated on: April 22,2024

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli

Updated on:April 22,2024

New method is better able to map immune response and paves way for new treatments

byKarolinska InstitutetSpatial transcriptomics–based method to map B cell and T cell receptors.Targeted capture of antigen receptor sequences from spatial transcriptomics gene expression librari

Updated on: January 26,2024

New method is better able to map immune response and paves way for new treatments

byKarolinska InstitutetSpatial transcriptomics–based method to map B cell and T cell receptors.Targeted capture of antigen receptor sequences from spatial transcriptomics gene expression librari

Updated on:January 26,2024

COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

by Maria Fernanda Ziegler,FAPESPThe systems immunology approach identifies an aging effect on autoantibody levels of COVID-19 patients. Credit:npj Aging(2023). DOI: 10.1038/s41514-02

Updated on: April 10,2024

COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

by Maria Fernanda Ziegler,FAPESPThe systems immunology approach identifies an aging effect on autoantibody levels of COVID-19 patients. Credit:npj Aging(2023). DOI: 10.1038/s41514-02

Updated on:April 10,2024

An asthma vaccine effective in mice

by Pasteur InstituteCredit: CC0 Public DomainInserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have d

Updated on: April 24,2024

An asthma vaccine effective in mice

by Pasteur InstituteCredit: CC0 Public DomainInserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have d

Updated on:April 24,2024